OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 134 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,853,000 | -56.7% | 4,310,537 | -43.4% | 0.00% | – |
| Q1 2016 | $4,283,000 | -58.9% | 7,613,291 | +25.7% | 0.00% | -100.0% |
| Q4 2015 | $10,417,000 | +7.3% | 6,056,482 | +31.7% | 0.00% | – |
| Q3 2015 | $9,704,000 | -56.7% | 4,599,187 | +1.7% | 0.00% | -100.0% |
| Q2 2015 | $22,387,000 | -24.5% | 4,522,769 | +19.4% | 0.00% | 0.0% |
| Q1 2015 | $29,660,000 | +33.5% | 3,787,986 | +3.3% | 0.00% | 0.0% |
| Q4 2014 | $22,216,000 | +39.7% | 3,666,005 | -1.8% | 0.00% | +100.0% |
| Q3 2014 | $15,907,000 | -14.0% | 3,734,125 | +24.8% | 0.00% | 0.0% |
| Q2 2014 | $18,493,000 | -3.8% | 2,992,272 | +1.2% | 0.00% | -50.0% |
| Q1 2014 | $19,221,000 | +23.0% | 2,957,081 | +6.6% | 0.00% | +100.0% |
| Q4 2013 | $15,621,000 | +0.4% | 2,774,713 | +9.5% | 0.00% | -50.0% |
| Q3 2013 | $15,565,000 | +19.6% | 2,534,946 | +13.9% | 0.00% | +100.0% |
| Q2 2013 | $13,017,000 | – | 2,225,096 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |